Authors
Min-Yu Wen, Guan-Jie Qin, Gao-Yuan Wang, Ling Li, Gui-Qiong Xu, Qin Zhou, Jing Huang, Zheng Wu, Kai-Bin Yang, Yu-Zhe Wang, Li Lin, Cheng Xu, Yu-Pei Chen, Xu Liu, Yuan Zhang, Rui Guo, Lei Chen, Yan-Ping Mao, Ling-Long Tang, Xiao-Dong Zhu, Feng Lei, Liang-Fang Shen, Kun-Yu Yang, Ya-Qian Han, Ji-Bin Li, Hao-Jiang Li, Shao Hui Huang, Li-Zhi Liu, Xiao-Jing Du, Jun Ma
Published in
Med (New York, N.Y.). Pages 101357. Nov 10, 2026. Epub Nov 10, 2026.
Abstract
The ninth edition of the TNM classification (TNM-9) for nasopharyngeal carcinoma (NPC) has been implemented but requires further validation and refinement.
A multicenter retrospective cohort of 6,049 patients with nonmetastatic NPC treated with intensity-modulated radiotherapy (IMRT) (2016-2017) was analyzed. Patients were restaged from TNM-8 to TNM-9 using pretreatment MRI. Overall survival (OS) was the primary endpoint. Prognostic performance was compared using multivariable Cox regression and Groome's criteria. Early skull base invasion (ESBI), cranial nerve foramen invasion (CNFI), and grade 2 imaging-detected extranodal extension (G2-iENE) were evaluated as potential refinements.
TNM-9 outperformed TNM-8 according to Groome's criteria, but category distribution remained imbalanced (T3, 44.3%; N1, 48.0%), and survival separation between T2 and T3 was limited despite statistical significance (5-year OS, 90.0% vs. 88.0%; p = 0.006). For the TNM-9 T category, T3_ESBI showed OS similar to T2 (adjusted hazard ratio [aHR] = 1.01, 95% confidence interval [CI] = 0.76-1.34, p = 0.94), whereas T3_CNFI demonstrated OS similar to T4 disease (aHR = 1.11, 95% CI = 0.85-1.44, p = 0.44). For the N category, N1_G2-iENE and N2 disease also had similar OS (aHR = 1.03, 95% CI = 0.79-1.34, p = 0.82). Reclassifying T3_ESBI as T2, T3_CNFI as T4, and N1_G2-iENE as N2 improved hazard discrimination and sample balance versus TNM-9.
Although TNM-9 outperforms TNM-8, limitations remain in T- and N-category discrimination and distribution balance. Incorporating ESBI, CNFI, and G2-iENE into the staging framework improves prognostic performance for NPC.
This study was supported by the Academician Workstation of J.M., the Specific Research Fund of the Innovation Platform for Academicians of Hainan Province, the Science and Technology Program of Guangzhou, and the Cancer Innovative Research Program of Sun Yat-sen University Cancer Center.
PMID:
43008736
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0